Skip to content


2020 Launch of the Global Sustainability Program that will enable us to step up our efforts to integrate sustainability into our business over the next years.
Production of the 2-billionth dialyzer – just seven years after the production of the 1-billionth.
2019 By acquiring NxStage Medical, Inc., Fresenius Medical Care expands its product portfolio with an innovative technology for home hemodialysis offering patients greater flexibility.
2018 Fresenius Medical Care launches the 4008A dialysis machine tailored to needs in emerging markets.
2016 Launch of the 6008 CAREsystem, a new hemodialysis therapy system, that delivers advanced dialysis therapy more easily, leaving more time for direct patient care.
2014 A new generation of home dialysis cyclers is launched – sleep•safe harmony – enabling most individualized treatment options with adapted APD (aAPD) therapy.
2013 Fresenius Medical Care produces the dialyzer.
2012 Fresenius Medical Care produces the 500,000th dialysis machine.
2011 The worldwide expansion of the service business continues by acquiring IDC, Liberty Dialysis Holdings Inc. and American Access Care.
2010 Foundation of a joint venture to develop and sell drugs for patients with chronic kidney disease.
2007 Fresenius Medical Care continues its success as the leading manufacturer of dialyzers, producing its 500,000,000th dialyzer
2006 Fresenius Medical Care acquired the U.S. dialysis care provider Renal Care Group, Inc. Through its network of around 2.000 dialysis clinics around the world the company provides dialysis treatments to approximately 157,000 patients. Fresenius Medical Care also transforms its legal form into KGaA
2005 The new dialysis therapy system 5008 is introduced in the market and wins the prize “Innovationspreis der Deutschen Wirtschaft".
2003 Fresenius Medical Care is the leading dialysis company caring for more than 119,000 patients in own dialysis centers worldwide. With a production output of more than 50 million dialyzers per year the company sets a new record.
1999 The 100,000th dialysis machine comes off the production line. Fresenius Medical Cares’ ordinary share is admitted to the DAX, Germany’s blue-chip share index.
1996 Fresenius Medical Care is founded from a merger of Fresenius Worldwide Dialysis and National Medical Care. The company’s shares are listed at the stock exchanges in Frankfurt and New York.
1983 The Company takes up the production of synthetic polysulfone fiber membranes for blood purification. These membranes today set the quality standards for dialyzers.
1979 In a newly acquired factory in Schweinfurt, Germany, the production of the A2008 dialysis machine begins. The new machine was very successful, and awarded a gold medal for technological innovation at the Leipzig Trade Fair.
1974 Fresenius starts to manufacture infusion solutions and medical disposables in St. Wendel, Germany. Today. Fresenius Medical Care produces highly innovative Polysulfone dialyzers in St. Wendel.
1966 Fresenius starts to sell dialysis machines and dialyzers manufactured by various foreign companies and gains substantial market shares.
1951 Else Fernau, later Else Kröner, takes over the responsibility for the pharmacy and company after she has obtained her degree in pharmacy studies
1934 The Production unit separated from the Hirsch Pharmacy and relocated to nearby Bad Homburg.
1912 Dr. Eduard Fresenius, pharmacist and proprietor of the Hirsch Pharmacy commences the production of pharmaceuticals.
1462 Foundation of the Hirsch Pharmacy in Frankfurt am Main. The Fresenius family assumes ownership in the 18th century.